§ Funding Round
Series B funding round for Metagenomi raising $180M in January 2022
Series B funding round for Metagenomi raising $180M in January 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Access Biotechnology | — | — |
| Organization | — | |
Connecticut Innovations | — | — |
| Organization | — | |
| Organization | — | |
Nextech Invest | — | — |
| Organization | — | |
| Organization | — | |
| Angel | jeremy yap | |
Bristol Myers Squibb | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Frazier Life Sciences | — | — |
Irving Investors | — | — |
| Organization | — | |
Marshall Wace | — | — |
Millennium Management | — | — |
| Organization | — | |
| Organization | — | |
| Angel | santhosh palani, phd, cfa | |
| Organization | — | |
| Organization | — | |
Surveyor Capital | — | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$550M
Top Valuation
-
Metagenomi raised $180M in a Series B round.
The round was announced on 01/01/22.
The round was led by Farallon Capital Management, santhosh palani, phd, cfa.
